1951
DOI: 10.1001/archderm.1951.01570110043006
|View full text |Cite
|
Sign up to set email alerts
|

Cortisone Acetate Administered Orally in Dermatologic Therapy

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

0
6
0

Year Published

1954
1954
2017
2017

Publication Types

Select...
10

Relationship

0
10

Authors

Journals

citations
Cited by 39 publications
(6 citation statements)
references
References 1 publication
0
6
0
Order By: Relevance
“…[ 3 ] TCS also have potent antipruritic, atrophogenic, melanopenic, immunosuppressive, and ex-hormone like effect on the skin. [ 4 ]…”
Section: Introductionmentioning
confidence: 99%
“…[ 3 ] TCS also have potent antipruritic, atrophogenic, melanopenic, immunosuppressive, and ex-hormone like effect on the skin. [ 4 ]…”
Section: Introductionmentioning
confidence: 99%
“…Topical corticosteroids (TCS) are of great value in treating a wide spectrum of dermatological diseases and since the time of its introduction in 1951, a new therapeutic era in dermatology has been emerged [1]. …”
Section: Introductionmentioning
confidence: 99%
“…Philip Hench, a clever rheumatologist at the Mayo Clinic, following a "hunch" consulted Kendall about the use of Compound E in the treatment of arthritis. This may have been one of the first controlled clinical trials in the USA: (Hench et al 1950) efficacy in arthritis was confirmed, a) oral cortisone for dermatologic diseases (Sulzberger et al 1951). Despite their many problems oral corticosteroids, mostly prednisone or prednisolone, are being used widely as anti-inflammatory oral agents, but not in psoriasis or atopic dermatitis, two important and still untreatable common diseases in dermatology.…”
Section: Immunomodulatorylanti-proliferative Agentsmentioning
confidence: 93%